Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Mast cells: an expanding pathophysiological role from allergy to other disorders.
Solodyn
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
MAIT cells in autoimmunity.
Neuromuscular taping in multiple sclerosis. A pilot study.
New Disease-Modifying Therapies and New Challenges for MS.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
Endogeneous Remyelination: Findings in Human Studies.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
Contribution of imaging to the diagnosis of optic neuropathies.
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.
Risk of vascular disease in patients with multiple sclerosis: a review.
Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
The role of complementary and alternative medicine in therapy of multiple sclerosis.
Pages
« first
‹ previous
…
138
139
140
141
142
143
144
145
146
…
next ›
last »